JP2006298814A - Skin lotion for acne - Google Patents

Skin lotion for acne Download PDF

Info

Publication number
JP2006298814A
JP2006298814A JP2005121893A JP2005121893A JP2006298814A JP 2006298814 A JP2006298814 A JP 2006298814A JP 2005121893 A JP2005121893 A JP 2005121893A JP 2005121893 A JP2005121893 A JP 2005121893A JP 2006298814 A JP2006298814 A JP 2006298814A
Authority
JP
Japan
Prior art keywords
extract
mango
agent
inhibitor
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005121893A
Other languages
Japanese (ja)
Inventor
Katsuyoshi Adachi
佳津良 足立
Takahiro Tada
貴広 多田
Kaname Aramaki
要 荒巻
Kazunori Sakaida
和則 阪井田
Yukimi Matsuo
幸美 松尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAKAMOTO YAKUSOEN KK
Mikimoto Pharmaceutical Co Ltd
Sakamoto Yakusoen KK
Original Assignee
SAKAMOTO YAKUSOEN KK
Mikimoto Pharmaceutical Co Ltd
Sakamoto Yakusoen KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAKAMOTO YAKUSOEN KK, Mikimoto Pharmaceutical Co Ltd, Sakamoto Yakusoen KK filed Critical SAKAMOTO YAKUSOEN KK
Priority to JP2005121893A priority Critical patent/JP2006298814A/en
Publication of JP2006298814A publication Critical patent/JP2006298814A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To utilize the extract of mango (Mangifera indica L.) effectively, of which effectiveness only as a health food is found until now. <P>SOLUTION: This mango extract has a lipase inhibitory effect and it is found out to improve acne, etc. Further by blending 1 kind or ≥2 kinds of any of specific medicines such as a humectant, a cell-activator, an anti-inflammatory agent, an antioxidant, a beautifully whitening agent, a hyaluronidase inhibitor, an anti-plasmin agent, an active oxygen inhibitor, a collagenase activity inhibitor, an antihistamine agent and an elastase inhibitor with the extract, a more effective skin lotion is obtained. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明品は、特定の属の植物から抽出された抽出物が皮膚常在菌のリパーゼ産生を優位に阻害することで、ニキビの形成を抑え、これと保湿剤、抗炎症剤、抗酸化剤、抗プラスミン剤、活性酸素抑制剤、抗ヒスタミン剤の特定した薬剤を組み合わせ配合することにより、さらに肌荒れの改善および予防効果が得られる皮膚外用剤に関する。 The product of the present invention has an extract extracted from a plant of a specific genus that preferentially inhibits the production of lipases from skin resident bacteria, thereby suppressing acne formation, and a moisturizer, anti-inflammatory agent, antioxidant agent Further, the present invention relates to an external preparation for skin which can further improve and prevent rough skin by combining and combining the specified agents of antiplasmin agent, active oxygen inhibitor and antihistamine.

マンゴー(Mangifera indica L.)とは、ウルシ科(Anacardiaceae)、マンゴー属(Mangifera)の植物、マンゴー(Mangifera indica L.)の果実であり、北インドからミャンマー、マレーシア原産の植物で、その生果は日本で生産される果実でもっともおいしい最高級品の果実とも言われている。マンゴー抽出物には化粧料、浴用剤、洗剤組成物への利用法が知られている(特許文献1〜2参照)。また、マンゴー種子抽出物には、口紅用組成物(特許文献3参照)、損傷毛の修復効果を有する頭髪・頭皮化粧料(特許文献4参照)、抗酸化性組成物(特許文献5参照)、静菌及び抗菌剤(特許文献6参照)への利用法が知られているが、それ以外での用途についてはこれまで知られていない。 Mango (Mangifera indica L.) is a plant of the family Uranaceae (Anacardiaceae), Mango genus (Mangifera), Mango (Mangifera indica L.). Is said to be the most delicious fruit produced in Japan. The mango extract is known for its use in cosmetics, bath preparations, and detergent compositions (see Patent Documents 1 and 2). In addition, the mango seed extract includes a composition for lipstick (see Patent Document 3), a hair / scalp cosmetic having an effect of repairing damaged hair (see Patent Document 4), and an antioxidant composition (see Patent Document 5). The use for bacteriostatic and antibacterial agents (see Patent Document 6) is known, but other uses have not been known so far.

アクネは、顔面や背部などの脂腺が多く存在する部分に出来る毛包腺系の炎症性疾患である。アクネ病態に深く関与しているP.acnesは健常人の皮膚にも存在する皮膚常在菌であり、細菌性リパーゼを産生する。産生されたリパーゼは皮脂中のトリグリセライドを分解して遊離脂肪酸が産生され、これによって角化が行進しコメドを形成するだけでなく、アクネ炎症の原因ともなる。アクネによって起こる炎症は肌を荒らし、さらにはニキビ痕として残り、健やかな肌を維持するのを妨げる。
特開2001−31552号公報 特開2001−39823号公報 特開平7−223924号公報 特開平9−208435号公報 特開平9−216836号公報 特開平10−324610号公報
Acne is an inflammatory disease of the follicular gland system that occurs in areas with many sebaceous glands such as the face and back. P. acnes, which is deeply involved in acne pathology, is a resident skin resident in healthy human skin and produces bacterial lipase. The produced lipase breaks down triglycerides in sebum to produce free fatty acids, which not only march and form comed but also cause acne inflammation. Inflammation caused by acne can irritate the skin and even leave it as acne scars, preventing it from maintaining healthy skin.
Japanese Patent Laid-Open No. 2001-31552 JP 2001-39823 A Japanese Patent Laid-Open No. 7-223924 JP-A-9-208435 Japanese Patent Laid-Open No. 9-216836 Japanese Patent Laid-Open No. 10-324610

本発明の目的は、有効性の高いマンゴー(Mangifera indica L.) の抽出物に関して有効に活用するために種々検討した。 The object of the present invention has been variously studied for effective use with respect to an extract of highly effective mango (Mangifera indica L.).

マンゴー(Mangifera indica L.)の抽出物がリパーゼ活性を阻害することを見出し、アクネ用皮膚外用剤として有効なことがわかった。
さらにマンゴーに特定の薬剤(保湿剤、抗炎症剤、抗酸化剤、抗プラスミン剤、活性酸素抑制剤、抗ヒスタミン剤など)を配合することによってより有効性の高い皮膚外用剤を見出した。
It was found that an extract of mango (Mangifera indica L.) inhibits lipase activity and was effective as a skin external preparation for acne.
Furthermore, a more effective skin external preparation was found by adding specific drugs (humectants, anti-inflammatory agents, antioxidants, antiplasmin agents, active oxygen inhibitors, antihistamines, etc.) to mango.

マンゴーの抽出物の形態はなんら限定されるものではないが、好ましくはマンゴー果実を陰乾し、粉砕後、抽出溶媒(例えばエタノール等のアルコール、水またはこれら混合)とともに、3日間浸漬または1時間100度にて加温、冷却、ろ過した液を使用する。 The form of the mango extract is not limited in any way. Preferably, the mango fruit is shade-dried, ground and then immersed in an extraction solvent (for example, alcohol such as ethanol, water or a mixture thereof) for 3 days or 100 hours for 1 hour. Use liquid that has been heated, cooled, and filtered.

試験;リパーゼ抑制試験
基質であるPentanoic acid 4-nitrophenyl eaterが酵素リパーゼにより加水分解され、生成される4-nitrophenyl esterの吸収を測定するリパーゼ抑制試験により、マンゴー(Mangifera indica L.)の抽出物についてリパーゼ活性阻害作用を調べた。0.04%オレフィンスルホン酸−50mM Tris緩衝液(pH7.7)で調製した試験品500μlに同緩衝液3ml、2mg/mlリパーゼ〔SIGMA〕酵素-50mM Tris緩衝液(pH7.7)500μlを添加、攪拌後、40℃で5分間インキュベートした。さらに基質として1mM PNP-valerate1mlを添加、攪拌し、40℃で15分間インキュベートした後、Abs.425nmにて吸光度(A)を測定した。同様に、酵素液の代替として緩衝液を用いた場合の吸光度(B)、試験品の代替として緩衝液を用いた場合の吸光度(C)、酵素液の代替として緩衝液をかつ試験品の代替として緩衝液を用いた場合の吸光度(D)を測定し、下記の数式よりリパーゼ活性阻害率(%)を算出した。
<数式>リパーゼ活性阻害率(%)=[1−(A−B)/(C−D)]×100
○試験品は以下に示す。
マンゴーE:マンゴー(果実乾燥物)(20g)のエタノール(100ml)エキス(凍結乾燥物)
マンゴーEW:マンゴー(果実乾燥物)(20g)の50%エタノール−水(100ml)エキス(凍結乾燥物)
Test: Lipase Inhibition Test Extract of mango (Mangifera indica L.) by lipase inhibition test in which the substrate Pentanoic acid 4-nitrophenyl eater is hydrolyzed by enzyme lipase and the absorption of 4-nitrophenyl ester produced is measured. Lipase activity inhibitory action was examined. Add 500 μl of the same buffer 3 ml, 2 mg / ml lipase [SIGMA] enzyme-50 mM Tris buffer (pH 7.7) to 500 μl of the test product prepared with 0.04% olefin sulfonic acid-50 mM Tris buffer (pH 7.7). After stirring, the mixture was incubated at 40 ° C. for 5 minutes. Further, 1 ml of 1 mM PNP-valerate was added as a substrate, stirred and incubated at 40 ° C. for 15 minutes, and then the absorbance (A) was measured at Abs. 425 nm. Similarly, Absorbance (B) when buffer is used as an alternative to enzyme solution, Absorbance (C) when buffer is used as alternative to test product, Buffer solution is used instead of enzyme solution, and Test product is used instead The absorbance (D) when a buffer solution was used was measured, and the lipase activity inhibition rate (%) was calculated from the following formula.
<Formula> Lipase activity inhibition rate (%) = [1- (AB) / (CD)] × 100
○ Test items are shown below.
Mango E: Mango (dried fruit) (20 g) in ethanol (100 ml) extract (freeze dried)
Mango EW: Mango (fruit dried product) (20 g) 50% ethanol-water (100 ml) extract (lyophilized product)

上記の試験のリパーゼ活性阻害率の結果はマンゴーE71.2%、マンゴーEWが50.3%であった。   As a result of the lipase activity inhibition rate in the above test, mango E was 71.2% and mango EW was 50.3%.

マンゴー(Mangifera indica L.) の抽出物は高いリパーゼ抑制効果を示した。マンゴー(Mangifera indica L.)の抽出物は0.0001〜10重量%で配合すれば阻害効果等を十分発揮することから、この濃度で配合することが望ましい。 Mango extract (Mangifera indica L.) showed high lipase inhibitory effect. Mango extract (Mangifera indica L.) extract is desirable to add at this concentration because it can sufficiently exert an inhibitory effect and the like when added at 0.0001 to 10% by weight.

また、マンゴー(Mangifera indica L.)の抽出物に特定の薬剤(保湿剤、細胞賦活剤、抗炎症剤、抗酸化剤、美白剤、抗プラスミン剤、活性酸素抑制剤、抗ヒスタミン剤など)を配合すると、アクネ、炎症、肌荒れなど種々の肌悩みを改善あるいは予防することがわかった。 In addition, when a specific drug (humectant, cell activator, anti-inflammatory agent, antioxidant, whitening agent, antiplasmin agent, active oxygen inhibitor, antihistamine, etc.) is added to the mango (Mangifera indica L.) extract It was found to improve or prevent various skin problems such as acne, inflammation and rough skin.

さらに水酸基を2つ以上含む多価アルコール、低級アルコール、界面活性剤、低分子ベタインのいずれか1種または2種以上を配合するとより効果が得られることもわかった。 Furthermore, it has also been found that the effect can be further obtained by blending one or more of polyhydric alcohols containing two or more hydroxyl groups, lower alcohols, surfactants, and low molecular betaines.

利用できる多価アルコールに特に限定はないが例示すれば、グリセリン、1,3ブチレングリコール、プロピレングリコール、イソプレングリコール、ソルビトール、トレハロース、マルトース等が挙げられる。これらを0.1〜80重量%、好ましくは1〜30重量%を配合するが、多価アルコールの種類によって配合量は変化し、また、複数の多価アルコールを利用できることはいうまでもない。   The polyhydric alcohol that can be used is not particularly limited, and examples thereof include glycerin, 1,3 butylene glycol, propylene glycol, isoprene glycol, sorbitol, trehalose, maltose and the like. These are blended in an amount of 0.1 to 80% by weight, preferably 1 to 30% by weight. Needless to say, the blending amount varies depending on the type of polyhydric alcohol, and a plurality of polyhydric alcohols can be used.

低級アルコールを配合することによって吸収性が向上する。低級アルコールの種類は種々あるが通常エタノールを用いる。配合量は特に限定はないが、2〜70重量%が好ましい。
マンゴー(Mangifera indica L.)の抽出物を含む多価アルコールの組み合わせに界面活性剤を併せて配合することも有効であり、さらに前記の低級アルコールをも合わせて配合することも有効である。
界面活性剤には特に限定はなく、用途や剤形によって種類や量を選択すればよい。
界面活性剤は、油剤等の乳化や可溶化等のために用いられ、アニオン性(アルキルカルボン酸塩、アルキルスルホン酸塩、アルキル硫酸エステル塩、アルキルリン酸エステル塩)、非イオン性(エーテル型非イオン界面活性剤、エーテルエステル型非イオン界面活性剤、エステル型非イオン界面活性剤、ブロックポリマー型非イオン界面活性剤、含窒素型非イオン界面活性剤)及び両性(カルボン酸型両性界面活性剤(アミノ型、ベタイン型)、硫酸エステル型両性界面活性剤、スルホン酸型両性界面活性剤、リン酸エステル型両性界面活性剤)その他の界面活性剤(天然界面活性剤、タンパク質加水分解物の誘導体、高分子界面活性剤、チタン・ケイ素を含む界面活性剤、フッ化炭素系界面活性剤)の活性剤を適宜用いることができる。
Absorbability improves by mix | blending a lower alcohol. Although there are various kinds of lower alcohols, ethanol is usually used. The blending amount is not particularly limited but is preferably 2 to 70% by weight.
It is also effective to combine a surfactant with a polyhydric alcohol combination containing an extract of mango (Indica L.), and it is also effective to combine the lower alcohol.
There is no particular limitation on the surfactant, and the type and amount may be selected depending on the application and dosage form.
Surfactants are used for emulsification and solubilization of oils, etc., and are anionic (alkyl carboxylates, alkyl sulfonates, alkyl sulfate esters, alkyl phosphate esters), nonionic (ether type) Nonionic surfactant, ether ester type nonionic surfactant, ester type nonionic surfactant, block polymer type nonionic surfactant, nitrogen-containing type nonionic surfactant) and amphoteric (carboxylic acid type amphoteric surfactant) Agents (amino type, betaine type), sulfate ester type amphoteric surfactant, sulfonic acid type amphoteric surfactant, phosphate ester type amphoteric surfactant) and other surfactants (natural surfactants, protein hydrolysates) Derivatives, polymer surfactants, surfactants containing titanium and silicon, and fluorocarbon surfactants) can be used as appropriate.

低分子ベタインも選択されるべき原料の1つであり、これを配合することによってさらに効果は向上し、且つ塗布感もよくなり、皮膚外用剤として有効性は増す。
利用できる低分子ベタインは、分子量200以下の、第四アンモニウム塩基、スルホニウム塩基、ホスホニウム塩基等の分子内塩で両性イオンを形成するものを包含し得る。例示すれば、トリメチルグリシン、N,N,N−トリメチルアラニン、N,N,N−トリメチルグルタミン酸、トリエチルグリシンなどがあるが、トリメチルグリシンが好適である。
なお、分子量200以上のものは界面活性能を有し、低分子ベタインの効果とは異なるもので、上述したように界面活性剤を用いることは本発明の効果を高めるが低分子ベタインとは効果が異なる。
Low molecular weight betaine is also one of the raw materials to be selected, and by blending this, the effect is further improved and the feeling of application is improved, and the effectiveness as an external preparation for skin is increased.
Low molecular weight betaines that can be utilized may include those that form zwitterions with internal salts such as quaternary ammonium bases, sulfonium bases, phosphonium bases and the like having a molecular weight of 200 or less. Examples include trimethylglycine, N, N, N-trimethylalanine, N, N, N-trimethylglutamic acid, triethylglycine, and the like, with trimethylglycine being preferred.
Those having a molecular weight of 200 or more have a surface-active ability, which is different from the effect of low molecular betaine. As described above, the use of a surfactant enhances the effect of the present invention, but the effect of low molecular betaine is Is different.

本発明の皮膚外用剤は、常法に従い、通常の皮膚外用剤として知られる種々の形態の基材に配合して調製することができる。   The external preparation for skin of the present invention can be prepared by blending with various forms of base materials known as normal external preparations for skin according to conventional methods.

外用剤の形態としては、特に限定されず、例えば、乳液、クリーム、水溶液、パック等の任意の剤形を選択することができる。 It does not specifically limit as a form of an external preparation, For example, arbitrary dosage forms, such as a milky lotion, cream, aqueous solution, a pack, can be selected.

本発明の皮膚外用剤には、上記した必須成分の他に通常の外用剤に配合される成分、例えば、油剤、粉体、精製水、高分子化合物、ゲル化剤、紫外線吸収剤、紫外線散乱剤、酸化防止剤、色素、防腐剤、香料、美容成分を本発明の効果を損なわない範囲で適宜選択して用いることができる。 In the external preparation for skin of the present invention, in addition to the above-mentioned essential components, components that are blended in normal external preparations, such as oils, powders, purified water, polymer compounds, gelling agents, UV absorbers, UV scattering Agents, antioxidants, pigments, preservatives, fragrances, and cosmetic ingredients can be appropriately selected and used within a range not impairing the effects of the present invention.

次に実施例及び比較例を挙げて本発明を更に詳細に説明するが、本発明はこれらになんら制約されるものではない。また、使用した薬剤の抽出液についての抽出方法は何ら限定されるものではない。
実施例及び比較例の処方を表1から表2に示す。作成方法は常法により行った。なお、表1はローション、表2は美容液の処方であり、配合量は重量部で示す。
EXAMPLES Next, although an Example and a comparative example are given and this invention is demonstrated still in detail, this invention is not restrict | limited at all to these. Moreover, the extraction method about the extract of the used chemical | medical agent is not limited at all.
Tables 1 and 2 show the formulations of Examples and Comparative Examples. The preparation method was performed by a conventional method. Table 1 shows the lotion and Table 2 shows the formulation of the cosmetic liquid, and the amount is shown in parts by weight.

Figure 2006298814
Figure 2006298814

Figure 2006298814
Figure 2006298814

上記の比較例および実施例に用いた原料についての詳細を以下に記す。
(注1)マンゴー抽出液はマンゴー(果実乾燥物)10gにエタノール200mlを加えて5日攪拌した後、ろ過した抽出液を用いた。
(注2)マンゴー抽出液はマンゴー(果実乾燥物)10gにエタノール100mlと精製水100mlを加えて5日攪拌した後、ろ過した抽出液を用いた。
(注3)加水分解コンキオリン液はコンキオリンを硫酸分解し、分子量1000以下のものを用いた。
(注4)菱の実抽出液は[栃本天海堂(株)製]を用いた。
(注5)ホオノキ抽出液はファルコレックスホオノキE[一丸ファルコス(株)製]を用いた。
(注6)グァバ抽出液はグァバの葉10gにエタノール300mlを加えて5日間放置後、ろ過した抽出液を用いた。
(注7)西河柳抽出液は西河柳エキス[日本精化(株)製]を用いた。
(注8)海藻抽出液はマリンパージ[一丸ファルコス(株)製]を用いた。
Details of the raw materials used in the above comparative examples and examples are described below.
(Note 1) As the mango extract, 200 ml of ethanol was added to 10 g of mango (fruit dried product) and stirred for 5 days, and then the filtered extract was used.
(Note 2) As the mango extract, 100 ml of ethanol and 100 ml of purified water were added to 10 g of mango (fruit dried product) and stirred for 5 days, and then the filtered extract was used.
(Note 3) The hydrolyzed conchiolin solution used was one having a molecular weight of 1000 or less, by hydrolyzing conchiolin.
(Note 4) [Tochimoto Tenkaido Co., Ltd.] was used as the Rhizono extract.
(Note 5) As the honoki extract, Falco Rex honoki E [manufactured by Ichimaru Falcos Co., Ltd.] was used.
(Note 6) As the guava extract, 300 ml of ethanol was added to 10 g of guava leaves and allowed to stand for 5 days, and then the filtered extract was used.
(Note 7) Nishi-Hayanagi extract [Nippon Seika Co., Ltd.] was used as the extract.
(Note 8) Marine purge [manufactured by Ichimaru Falcos Co., Ltd.] was used as the seaweed extract.

表1〜表2記載の実施例1〜8及び比較例1〜2につき、アクネ改善試験を実施した。試験方法は25〜55才の女性20名をパネルとし、毎日朝と夜の2回、12週間にわたって洗顔後に被験外用剤の適量を顔面に塗布した。結果を表3に示す。 The acne improvement test was implemented about Examples 1-8 of Tables 1-2, and Comparative Examples 1-2. The test method consisted of 20 females aged 25 to 55 years old, and a suitable amount of a topical preparation was applied to the face after washing the face twice a day in the morning and night for 12 weeks. The results are shown in Table 3.

Figure 2006298814
Figure 2006298814

Claims (3)

マンゴー(Mangifera indica L.)の抽出物を配合することを特徴とするアクネ用皮膚外用剤。 A skin external preparation for acne, which is characterized by containing an extract of mango (Mangifera indica L.). マンゴー(Mangifera indica L.)の抽出物を配合することを特徴とするリパーゼ阻害剤 Lipase inhibitor characterized by containing an extract of mango (Mangifera indica L.) マンゴー(Mangifera indica L.)の抽出物と保湿剤、抗炎症剤、抗酸化剤、抗プラスミン剤、活性酸素抑制剤、抗ヒスタミン剤のいずれか1種または2種以上を含む皮膚外用剤 An external preparation for skin containing one or more of mango extract (Mangifera indica L.) and moisturizer, anti-inflammatory agent, antioxidant agent, antiplasmin agent, active oxygen inhibitor, antihistamine agent
JP2005121893A 2005-04-20 2005-04-20 Skin lotion for acne Pending JP2006298814A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005121893A JP2006298814A (en) 2005-04-20 2005-04-20 Skin lotion for acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005121893A JP2006298814A (en) 2005-04-20 2005-04-20 Skin lotion for acne

Publications (1)

Publication Number Publication Date
JP2006298814A true JP2006298814A (en) 2006-11-02

Family

ID=37467311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005121893A Pending JP2006298814A (en) 2005-04-20 2005-04-20 Skin lotion for acne

Country Status (1)

Country Link
JP (1) JP2006298814A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2700431A1 (en) * 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function
US20170049690A1 (en) * 2014-04-30 2017-02-23 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of aging using a combination of extracts
US10123964B2 (en) 2014-04-30 2018-11-13 Kimberly-Clark Worldwide, Inc. Topical composition including a combination of extracts for reducing signs of skin aging
CN113712856A (en) * 2021-09-08 2021-11-30 丽江黄小芒农业科技有限责任公司 Daily chemical product with anti-radiation water replenishing oil and preparation method thereof
WO2022090322A1 (en) * 2020-10-28 2022-05-05 Givaudan Sa Improvements in or relating to extracts

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2700431A1 (en) * 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function
US20170049690A1 (en) * 2014-04-30 2017-02-23 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of aging using a combination of extracts
US10071049B2 (en) * 2014-04-30 2018-09-11 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of skin aging using a combination of extracts
US10123964B2 (en) 2014-04-30 2018-11-13 Kimberly-Clark Worldwide, Inc. Topical composition including a combination of extracts for reducing signs of skin aging
WO2022090322A1 (en) * 2020-10-28 2022-05-05 Givaudan Sa Improvements in or relating to extracts
CN113712856A (en) * 2021-09-08 2021-11-30 丽江黄小芒农业科技有限责任公司 Daily chemical product with anti-radiation water replenishing oil and preparation method thereof

Similar Documents

Publication Publication Date Title
JP2006131633A (en) Use of urea compound for suppressing aging sign of skin
WO2008066193A1 (en) Cosmetic composition
US10792258B2 (en) Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
EP0937453A2 (en) Cosmetic and tissue cleansing and moisturizing composition
JP2008069075A (en) Skin care composition
US20020012697A1 (en) Cosmetic and tissue cleansing and moisturizing composition
JPH07277939A (en) Skin external preparation
JP2006219448A (en) External preparation for skin for acne
RU2282435C2 (en) Pharmaceutical composition for prophylaxis or treatment of seborrhea, method for prophylaxis or treatment of seborrhea
JP2006298814A (en) Skin lotion for acne
JP2005047910A (en) Sebum secretion-inhibiting composition
JP2003221328A (en) Skincare agent
JPWO2012042970A1 (en) Preventive or therapeutic agent for atopic dermatitis, and external preparation
JP2010070496A (en) Agent for promoting production of hair and/or hair follicle reinforcing factor
EP1557161A1 (en) Method for cleansing sensitive skin using an alkanolamine
JPH09268121A (en) Preparation for external use for skin
JP5455292B2 (en) Skin external composition
JPH10251155A (en) Protease inhibitor
JP2001172155A (en) Skin preparation for external use
JP2006169225A (en) External agent for preventing skin aging
TWI780699B (en) Lactoferrin, derived peptides thereof and a use thereof for inhibiting and/or alleviating lipid synthesis
JP2004315492A (en) Anti-aging cosmetic
JP6209350B2 (en) Acne control composition, external preparation for skin and cosmetics
JP2011231055A (en) Cosmetic for skin
KR102038366B1 (en) Cosmetic composition for improving acne skin